亚洲有码中文字幕_啊啊啊在线视频_婷婷五月天成人高清无码_91美女操逼_亚洲AV成人片无码精品花岛_思思操思思热思思干SM_男女网站免费观看_成人精品97久久_欧美激情精品久久久久久变态_操逼视频免费无码_天堂久久网_激情88色色色_亚洲性爱视频在线播放_超碰在线干_成人激情av

北京索萊寶科技

專(zhuān)注于生物學(xué)試劑及試劑盒領(lǐng)域

服務(wù)熱線(xiàn):18101056239

產(chǎn)品中心

PRODUCTS CENTER

當(dāng)前位置:首頁(yè)產(chǎn)品中心抗體Polyclonal AntibodyK106708PAnti-VASH1 Polyclonal Antibody

Anti-VASH1 Polyclonal Antibody
產(chǎn)品簡(jiǎn)介:

Anti-VASH1 Polyclonal Antibody
應(yīng)用 WB
稀釋比例WB 1:500-2000.
交叉反應(yīng)Human

產(chǎn)品型號(hào):K106708P

更新時(shí)間:2022-08-14

廠商性質(zhì):生產(chǎn)廠家

訪(fǎng) 問(wèn) 量 :933

服務(wù)熱線(xiàn)

010-50973130

立即咨詢(xún)
產(chǎn)品介紹

Anti-VASH1 Polyclonal Antibody

英文名稱(chēng)Anti-VASH1 Polyclonal Antibody
宿主Rabbit
別名KIAA1036;VASH;Vasohibin-1
應(yīng)用WB
稀釋比例WB 1:500-2000.
交叉反應(yīng)Human
蛋白分子量41kDa
Gene ID22846
保存Store at -20°C. Avoid freeze / thaw cycles.
儲(chǔ)存液Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
純化方法Affinity purification
亞型IgG
免疫原A synthetic peptide of human VASH1
性狀液體
Public Immunogen RangeA synthetic peptide of human VASH1
Subcellular LocationsSecreted
Swiss ProtQ7L8A9
克隆類(lèi)型Polyclonal Antibody
背景資料Angiogenesis inhibitor. Inhibits migration, proliferation and network formation by endothelial cells as well as angiogenesis. This inhibitory effect is selective to endothelial cells as it does not affect the migration of smooth muscle cells or fibroblasts. Does not affect the proliferation of cancer cells in vitro, but inhibits tumor growth and tumor angiogenesis. Acts in an autocrine manner. Inhibits artery neointimal formation and macrophage infiltration. Exhibits heparin-binding activity.

在線(xiàn)留言

ONLINE MESSAGE

留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話(huà):

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7
  • 服務(wù)熱線(xiàn) 010-50973130
  • 電子郵箱

    3193328036@qq.com

掃碼加微信

Copyright © 2025 北京索萊寶科技有限公司版權(quán)所有    備案號(hào):

技術(shù)支持:化工儀器網(wǎng)    sitemap.xml

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |